Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Descending Monoaminergic Pain Inhibitory Pathway
- Molecular classification
- Neural pathway, Neuromodulatory system
01
Overview
The descending monoaminergic pain inhibitory pathway is a neural circuit originating in the brainstem (locus coeruleus and rostral ventromedial medulla) that projects to the spinal cord. It modulates pain by releasing noradrenaline, serotonin, and dopamine in the dorsal horn of the spinal cord, inhibiting nociceptive transmission. This pathway is a key target for drugs used to treat chronic and neuropathic pain.
- Other names
- Descending pain inhibitory pathwayDescending serotonergic pain pathwayDescending noradrenergic pain pathwayDescending monoamine pathway for pain modulation
02
Mechanism of action
Enhancing monoaminergic neurotransmission (noradrenaline, serotonin, dopamine) in the spinal cord dorsal horn to inhibit ascending nociceptive signals.
03
Biological functions
Pain modulationNociception inhibitionDescending control of spinal cord activityAnalgesia
04
Disease associations
Chronic painNeuropathic painFibromyalgiaMigraine
05
Safety considerations
Side effects associated with TCAs and SNRIs (e.g., cardiovascular effects, anticholinergic effects)Tolerance and dependence with chronic opioid usePotential for paradoxical pain facilitation with certain serotonergic drugs (depending on receptor subtype activation)Variability in individual response to drugs targeting this pathway
06
Interacting drugs
Tricyclic antidepressants (TCAs)
3 more in the full profile.
07
Biomarkers
Expression levels of α2-adrenoceptorsSerotonin and noradrenaline levels in cerebrospinal fluidGenetic polymorphisms affecting monoamine neurotransmission
Beyond the preview
Go deeper on Descending Monoaminergic Pain Inhibitory Pathway.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Descending Monoaminergic Pain Inhibitory Pathway.